Email this article STUDY OF NEUROTROPHIC PROPERTIES OF DRUGS THAT MODIFY THE COURSE OF MULTIPLE SCLEROSIS, THE FIRST AND SECOND LINES
- Authors: Baidina TV1, Medvedeva EV2, Trushnikova TN2
-
Affiliations:
- Perm State Medical University of Academician E.A. Wagner
- Perm Regional Clinical Hospital
- Issue: Vol XLIX, No 3 (2017)
- Pages: 109-110
- Section: Articles
- URL: https://journals.rcsi.science/1027-4898/article/view/14104
- DOI: https://doi.org/10.17816/nb14104
- ID: 14104
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
T V Baidina
Perm State Medical University of Academician E.A. Wagnerкафедра неврологии им.В.П.Первушина Perm
E V Medvedeva
Perm Regional Clinical Hospitalцентр рассеянного склероза Perm
T N Trushnikova
Perm Regional Clinical Hospital
Email: trushnikova.t@mail.ru
центр рассеянного склероза Perm
References
- Байдина Т.В., Куклина Е.М., Трушникова Т.Н. и др. Патогенетические и клинические особенности рассеянного склероза // Пермский медицинский журнал. 2016. Т. 33. № 4. С. 17-22.
- Yoshimura S., Ochi H., Isobe N., Matsushita T., Motomura K. Altered production of brain-derived neurotrophic factor by peripheral blood immune cells in multiple sclerosis // Multiple sclerosis journal. 2010. Vol. 16. P. 1178-1188.
- Waterhouse E.G., Xu B. New insights into the role of brain - derived neurotrophic factor in synaptic plasticity // Mol Cell Neurosci. N. Y., 2009. №42. Р. 81-89.
- Tongiorgi E., Sartori A., Baj G., Bratina A. Altered serum content of brain-derived neurotrophic factor isoforms in multiple sclerosis // J. Neurol Sci. 2012. Vol. 320(1-2). P.161-165.
